Sepracor acquires Oryx for $50 million Congressional Democrats draft legislation to reverse pre-emption ruling Merck, Health Interactions look to improve conversation on diabetes Wal-Mart continues to expand its healthcare offerings FDA approves Ipca's generic Inderal Calif. AG announces plan to combat prescription drug abuse ONC releases HIT plan Antibody drug found cost-effective against allergic asthma NACDS supports the adoption of HIT, emphasizes need for privacy Chinese firm approved to produce five herbal patches First Previous 2481 2482 2483 2484 2485 Next Last
